Florida’s Road to the Kentucky Derby kicks off on Saturday with the running of the $275,000 Holy Bull (G3) at Gulfstream Park ...
The IB PYP at XCL World Academy embeds future skills into primary education, preparing students for secondary school and ...
To achieve that goal, career-infused degree maps combine academic coursework and career milestones to inform and prepare students for careers or advanced education, so they understand their academic ...
Introduction High-risk pregnant women with physical or obstetric complications may develop depression and anxiety disorders that may worsen depending on the consequences of treatment and management ...
Mpox may be spreading more widely in Africa than previously thought because of asymptomatic transmission, according to new ...
Are you interested in knowing the approved rehabilitation schools in Kenya? Read on to discover the full list of these schools and where they are located.
IB schools in Kenya include the International School of Kenya, Aga Khan Academy in Nairobi and Mombasa, Braeburn Schools, The Nairobi Academy, and St. Mary's School. These schools deliver a demanding, ...
For many students dreaming of studying abroad, choosing the International Baccalaureate (IB) feels like picking the “right” future early on. The IB is often called the gold standard of school ...
Sweden headquartered IRLAB, a company focused on discovering and developing new treatments for Parkinson's disease, has received regulatory and ethical approvals for a phase Ib study of IRL757 to ...
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / December 23, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A ...
LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis
CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. ("LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered ...
Shares of Arcus Biosciences, Inc. RCUS, a clinical-stage biopharmaceutical company, declined 14.4% following the announcement that its late-stage STAR-221 study was discontinued for futility. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results